Senti Biosciences
SNTI
SNTI
25 hedge funds and large institutions have $7.56M invested in Senti Biosciences in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 6 closing their positions.
Holders
25
Holders Change
-1
Holders Change %
-3.85%
% of All Funds
0.37%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
5
Increased
5
Reduced
1
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
8GI
1
8VC GP I
Austin,
Texas
|
$1.67M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$467K |
| 3 |
AIM
3
ARK Investment Management
St. Petersburg,
Florida
|
$1.3M |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$28.8K |
| 5 |
5
Two Sigma Investments
New York
|
$18.9K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
T. Rowe Price Associates
Baltimore,
Maryland
| – | – | -3,147,123 | Closed |
|
27
TD Asset Management
Toronto,
Ontario, Canada
| – | – | -241,208 | Closed |
|
28
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | – | -110,973 | Closed |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | – | -496 | Closed |
|
30
UBS Group
Zurich,
Switzerland
| – | – | -202 | Closed |
|
31
Morgan Stanley
New York
| – | – | -1 | Closed |
|
|
CFGS
32
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|